US 7,608,262 B2
	Methods of preventing or treating thrombosis with tumor necrosis factor antagonists
Michael J. Elliott, London (United Kingdom); Ravinder N. Maini, London (United Kingdom); and Marc Feldmann, London (United Kingdom)
Assigned to The Kennedy Institute of Rheumatology, London (United Kingdom)
Filed on Feb. 16, 1996, as Appl. No. 8/602,272.
Prior Publication US 2002/0081306 A1, Jun. 27, 2002
Int. Cl. A61K 39/395 (2006.01)

U.S. Cl. 424—141.1  [424/145.1; 424/172.1]

1 Claim

1. A method of treating a thrombotic disorder in an individual in need thereof comprising administering a therapeutically effective amount of an anti-human tumor necrosis factor-α monoclonal antibody or antigen-binding fragment thereof to the individual, wherein the thrombotic disorder is deep vein thrombosis.